{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:49:03Z","timestamp":1762145343299,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL007954","NS084475","NS076631","T32 HL007638"],"award-info":[{"award-number":["T32 HL007954","NS084475","NS076631","T32 HL007638"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.celrep.2018.03.117","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T04:07:46Z","timestamp":1524629266000},"page":"1020-1033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cardiac mTORC1 Dysregulation Impacts Stress Adaptation and Survival in Huntington\u2019s Disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Daniel D.","family":"Child","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine J.","family":"Pascua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Mas Monteys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly L.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2018.03.117_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3233\/JHD-130054","article-title":"Cardiac dysautonomia in Huntington\u2019s disease","volume":"2","author":"Abildtrup","year":"2013","journal-title":"J.\u00a0Huntingtons Dis."},{"key":"10.1016\/j.celrep.2018.03.117_bib2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1468-1331.2008.02173.x","article-title":"Cardiovagal modulation upon postural change is altered in Huntington\u2019s disease","volume":"15","author":"B\u00e4r","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.celrep.2018.03.117_bib3","doi-asserted-by":"crossref","first-page":"31101","DOI":"10.1074\/jbc.M503763200","article-title":"The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity","volume":"280","author":"Basso","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.03.117_bib4","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/hc3601.096307","article-title":"Attenuated myocardial vasodilator response in patients with hypertensive hypertrophy revealed by oxygenation-dependent magnetic resonance imaging","volume":"104","author":"Beache","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.celrep.2018.03.117_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13630","article-title":"Neurocardiovascular pathology in Premanifest and Early Stage Huntington\u2019s Disease","author":"Bellosta Diago","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.celrep.2018.03.117_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/01.RES.81.2.176","article-title":"Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase","volume":"81","author":"Boluyt","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.celrep.2018.03.117_bib7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celrep.2018.03.117_bib8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbrc.2006.03.220","article-title":"Localization of Rheb to the endomembrane is critical for its signaling function","volume":"344","author":"Buerger","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2018.03.117_bib9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1474-4422(15)00177-5","article-title":"Treating the whole body in Huntington\u2019s disease","volume":"14","author":"Carroll","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2018.03.117_bib10","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.aag1417","article-title":"Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex","volume":"355","author":"Castellano","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.celrep.2018.03.117_bib11","doi-asserted-by":"crossref","first-page":"32493","DOI":"10.1074\/jbc.C300226200","article-title":"Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner","volume":"278","author":"Castro","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.03.117_bib12","unstructured":"CDC. (1994). National Health and Nutrition Examination Survey: NHANES III (1988-1994). https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/nhanes3\/default.aspx."},{"key":"10.1016\/j.celrep.2018.03.117_bib13","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","article-title":"Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington\u2019s disease following chronic energy deprivation","volume":"19","author":"Chaturvedi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2018.03.117_bib14","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.cellsig.2015.06.009","article-title":"The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications","volume":"27","author":"Cotecchia","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.celrep.2018.03.117_bib15","doi-asserted-by":"crossref","first-page":"e13289","DOI":"10.14814\/phy2.13289","article-title":"Neurocardiovascular deficits in the Q175 mouse model of Huntington\u2019s disease","volume":"5","author":"Cutler","year":"2017","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.celrep.2018.03.117_bib16","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/MCB.00985-10","article-title":"Rheb is essential for murine development","volume":"31","author":"Goorden","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.celrep.2018.03.117_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jnnp.2003.017822","article-title":"Rate and correlates of weight change in Huntington\u2019s disease","volume":"75","author":"Hamilton","year":"2004","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.celrep.2018.03.117_bib18","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.03.117_bib19","doi-asserted-by":"crossref","first-page":"15881","DOI":"10.1038\/srep15881","article-title":"The Akt-mTOR axis is a pivotal regulator of eccentric hypertrophy during volume overload","volume":"5","author":"Ikeda","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2018.03.117_bib20","unstructured":"Ionis Pharmaceuticals. (2017). Ionis Pharmaceuticals Licenses IONIS-HTTRx to Partner Following Successful Phase 1\/2a Study in Patients with Huntington\u2019s Disease. PRNewswire, December 11, 2017. http:\/\/ir.ionispharma.com\/news-releases\/news-release-details\/ionis-pharmaceuticals-licenses-ionis-htt-rx-partner-following."},{"key":"10.1016\/j.celrep.2018.03.117_bib21","doi-asserted-by":"crossref","first-page":"32845","DOI":"10.1074\/jbc.M114.612424","article-title":"Forkhead transcription factor FOXO3a levels are increased in Huntington disease because of overactivated positive autofeedback loop","volume":"289","author":"Kannike","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.03.117_bib22","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/endo.132.5.8477647","article-title":"Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching","volume":"132","author":"Kinnunen","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.celrep.2018.03.117_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1468-1331.2004.00894.x","article-title":"Early sympathetic hyperactivity in Huntington\u2019s disease","volume":"11","author":"Kobal","year":"2004","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.celrep.2018.03.117_bib24","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1988.00520320068017","article-title":"Conditions associated with Huntington\u2019s disease at death. A case-control study","volume":"45","author":"Lanska","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.celrep.2018.03.117_bib25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1212\/WNL.38.5.769","article-title":"Huntington\u2019s disease mortality in the United States","volume":"38","author":"Lanska","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2018.03.117_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2018.03.117_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuron.2014.12.019","article-title":"Reinstating aberrant mTORC1 activity in Huntington\u2019s disease mice improves disease phenotypes","volume":"85","author":"Lee","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2018.03.117_bib28","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbalip.2014.12.018","article-title":"The impairment of cholesterol metabolism in Huntington disease","volume":"1851","author":"Leoni","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.celrep.2018.03.117_bib29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0896-6273(93)90127-D","article-title":"Huntington\u2019s disease gene (IT15) is widely expressed in human and rat tissues","volume":"11","author":"Li","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2018.03.117_bib30","doi-asserted-by":"crossref","first-page":"35803","DOI":"10.1074\/jbc.M705231200","article-title":"Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb","volume":"282","author":"Li","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.03.117_bib31","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/onc.2013.273","article-title":"The FoxO-BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress","volume":"33","author":"Lin","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2018.03.117_bib32","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington\u2019s disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celrep.2018.03.117_bib33","doi-asserted-by":"crossref","first-page":"e1004024","DOI":"10.1371\/journal.pgen.1004024","article-title":"Huntington\u2019s disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart","volume":"9","author":"Melkani","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.celrep.2018.03.117_bib34","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2018.03.117_bib35","doi-asserted-by":"crossref","first-page":"e108961","DOI":"10.1371\/journal.pone.0108961","article-title":"The Huntington\u2019s disease-related cardiomyopathy prevents a hypertrophic response in the R6\/2 mouse model","volume":"9","author":"Mielcarek","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2018.03.117_bib36","doi-asserted-by":"crossref","first-page":"e1004550","DOI":"10.1371\/journal.pgen.1004550","article-title":"Dysfunction of the CNS-heart axis in mouse models of Huntington\u2019s disease","volume":"10","author":"Mielcarek","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.celrep.2018.03.117_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nbd.2006.09.016","article-title":"Cardiac dysfunction in the R6\/2 mouse model of Huntington\u2019s disease","volume":"25","author":"Mihm","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.celrep.2018.03.117_bib38","series-title":"Genetic Instabilities and Hereditary Neurological Diseases","first-page":"301","article-title":"Huntington\u2019s Disease","author":"Myers","year":"1998"},{"key":"10.1016\/j.celrep.2018.03.117_bib39","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0735-1097(01)01792-2","article-title":"Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction","volume":"39","author":"Norton","year":"2002","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.celrep.2018.03.117_bib40","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.107.750232","article-title":"Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure","volume":"117","author":"Pattison","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.celrep.2018.03.117_bib41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cvr\/cvs426","article-title":"FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival","volume":"97","author":"Puthanveetil","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.celrep.2018.03.117_bib42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2018.03.117_bib43","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/j.1460-9568.2004.03783.x","article-title":"Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington\u2019s disease mutation","volume":"20","author":"Ribchester","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.celrep.2018.03.117_bib44","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1212\/WNL.57.6.1025","article-title":"Striatal volume loss in HD as measured by MRI and the influence of CAG repeat","volume":"57","author":"Rosas","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2018.03.117_bib45","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1157535","article-title":"The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1","volume":"320","author":"Sancak","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.celrep.2018.03.117_bib46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2018.03.117_bib47","doi-asserted-by":"crossref","first-page":"e0147269","DOI":"10.1371\/journal.pone.0147269","article-title":"Cardiac dysfunction in the BACHD mouse model of Huntington\u2019s disease","volume":"11","author":"Schroeder","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2018.03.117_bib48","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/archneur.56.10.1248","article-title":"Sympathetic skin response and heart rate variability in patients with Huntington disease","volume":"56","author":"Sharma","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.celrep.2018.03.117_bib49","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1152\/ajpendo.00630.2010","article-title":"Molecular characterization of skeletal muscle atrophy in the R6\/2 mouse model of Huntington\u2019s disease","volume":"301","author":"She","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.celrep.2018.03.117_bib50","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.110.977066","article-title":"Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice","volume":"123","author":"Shende","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.celrep.2018.03.117_bib51","doi-asserted-by":"crossref","first-page":"C1256","DOI":"10.1152\/ajpcell.00338.2010","article-title":"mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy","volume":"299","author":"Song","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.celrep.2018.03.117_bib52","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jmg.29.12.911","article-title":"Causes of death in patients with Huntington\u2019s disease and in unaffected first degree relatives","volume":"29","author":"S\u00f8rensen","year":"1992","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.celrep.2018.03.117_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-130057","article-title":"Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington\u2019s disease","volume":"2","author":"Stanek","year":"2013","journal-title":"J.\u00a0Huntingtons Dis."},{"key":"10.1016\/j.celrep.2018.03.117_bib54","doi-asserted-by":"crossref","first-page":"10176","DOI":"10.1074\/jbc.M112.423640","article-title":"Rheb (Ras homologue enriched in brain)-dependent mammalian target of rapamycin complex 1 (mTORC1) activation becomes indispensable for cardiac hypertrophic growth after early postnatal period","volume":"288","author":"Tamai","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.03.117_bib55","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2018.03.117_bib56","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.bbadis.2016.08.019","article-title":"An impaired metabolism of nucleotides underpins a novel mechanism of cardiac remodeling leading to Huntington\u2019s disease related cardiomyopathy","volume":"1862","author":"Toczek","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.celrep.2018.03.117_bib57","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0595-104","article-title":"Cellular localization of the Huntington\u2019s disease protein and discrimination of the normal and mutated form","volume":"10","author":"Trottier","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2018.03.117_bib58","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2018.03.117_bib59","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2018.03.117_bib60","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1074\/mcp.O111.014704","article-title":"PaxDb, a database of protein abundance averages across all three domains of life","volume":"11","author":"Wang","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.celrep.2018.03.117_bib61","doi-asserted-by":"crossref","first-page":"e1006038","DOI":"10.1371\/journal.pgen.1006038","article-title":"Genetic dissection of cardiac remodeling in an isoproterenol-induced heart failure mouse model","volume":"12","author":"Wang","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.celrep.2018.03.117_bib62","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2018.03.117_bib63","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nature13319","article-title":"Mass-spectrometry-based draft of the human proteome","volume":"509","author":"Wilhelm","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2018.03.117_bib64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JHD-2012-120004","article-title":"Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington\u2019s disease","volume":"1","author":"Wood","year":"2012","journal-title":"J.\u00a0Huntingtons Dis."},{"key":"10.1016\/j.celrep.2018.03.117_bib65","doi-asserted-by":"crossref","first-page":"19793","DOI":"10.1074\/jbc.C600028200","article-title":"Hyperactivation of mammalian target of rapamycin (mTOR) signaling by a gain-of-function mutant of the Rheb GTPase","volume":"281","author":"Yan","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2018.03.117_bib66","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI43008","article-title":"MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice","volume":"120","author":"Zhang","year":"2010","journal-title":"J.\u00a0Clin. Invest."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124718304935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124718304935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:21:53Z","timestamp":1761906113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124718304935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2211124718304935"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2018.03.117","relation":{},"ISSN":["2211-1247"],"issn-type":[{"type":"print","value":"2211-1247"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac mTORC1 Dysregulation Impacts Stress Adaptation and Survival in Huntington\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2018.03.117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}